---
title: "Wedbush Keeps Their Buy Rating on Bicara Therapeutics Inc. (BCAX)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286216781.md"
description: "Wedbush analyst has maintained a Buy rating on Bicara Therapeutics Inc. (BCAX) with a price target of $30.00, while the shares closed at $22.38. The analyst consensus is a Strong Buy with an average price target of $30.99, indicating a potential upside of 38.47%. Additionally, Stifel Nicolaus also holds a Buy rating with a price target of $46.00."
datetime: "2026-05-13T07:35:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286216781.md)
  - [en](https://longbridge.com/en/news/286216781.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286216781.md)
---

# Wedbush Keeps Their Buy Rating on Bicara Therapeutics Inc. (BCAX)

Wedbush analyst maintained a Buy rating on Bicara Therapeutics Inc. yesterday and set a price target of $30.00. The company’s shares closed yesterday at $22.38.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Currently, the analyst consensus on Bicara Therapeutics Inc. is a Strong Buy with an average price target of $30.99, implying a 38.47% upside from current levels. In a report released yesterday, Stifel Nicolaus also maintained a Buy rating on the stock with a $46.00 price target.

### Related Stocks

- [BCAX.US](https://longbridge.com/en/quote/BCAX.US.md)

## Related News & Research

- [Bicara Therapeutics Touts Cancer Drug Progress Ahead of 2026 Pivotal Data](https://longbridge.com/en/news/286469142.md)
- [LifeSci Capital Remains a Buy on Maze Therapeutics, Inc. (MAZE)](https://longbridge.com/en/news/286649223.md)
- [LifeSci Capital Sticks to Its Buy Rating for Spyre Therapeutics (SYRE)](https://longbridge.com/en/news/286679543.md)
- [Bank of America Securities Reaffirms Their Buy Rating on Inhibikase Therapeutics (IKT)](https://longbridge.com/en/news/286542293.md)
- [Capstone Companies, Inc. announces Execution of Binding Letter of Intent with eBliss Global, Inc. | CAPC Stock News](https://longbridge.com/en/news/286782166.md)